IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA panel recommends Moderna booster for people over age 65


The FDA Vaccines and Related Biological Products Advisory Committee voted in favor of recommending the emergency use authorization for the Moderna Covid-19 booster dose. The booster will be available for those 65 years and older, immune compromised and those with occupations that put them at risk for severe disease.